STOK STOKE THERAPEUTICS INC US FDA Inspections 8-K Filing 2023 - FDA Approval for Higher Single Dose of STK-001 Stoke Therapeutics announces FDA approval for higher single dose of STK-001 in Dravet syndrome study.Get access to all SEC 8-K filings of the STOKE THERAPEUTICS INC